A Study to Evaluate the Pharmacokinetic Effects of Different Storage Conditions for a Long-Acting Nanosuspension of Rilpivirine on Pharmacokinetics
Condition(s):Human Immunodeficiency Virus Type 1Last Updated:November 14, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Human Immunodeficiency Virus Type 1Last Updated:November 14, 2018Completed
Condition(s):HealthyLast Updated:September 22, 2015Completed
Condition(s):HealthyLast Updated:November 4, 2014Completed
Condition(s):Hepatitis C Virus InfectionLast Updated:April 12, 2016Completed
Condition(s):Hepatitis C Virus InfectionLast Updated:April 4, 2016Completed
Condition(s):Healthy; Biological AvailabilityLast Updated:March 18, 2014Completed
Condition(s):Healthy ParticipantsLast Updated:October 24, 2013Completed
Condition(s):Hepatic ImpairmentLast Updated:November 11, 2013Completed
Condition(s):Multi-drug Resistant TuberculosisLast Updated:December 2, 2015Withdrawn
Condition(s):TuberculosisLast Updated:November 27, 2017Approved for marketing
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.